ArticleFood chemistry: X2026
Novel ternary covalent complexes (OsrhLF-EGCG-Mal) based on plant-derived recombinant lactoferrin (OsrhLF) by polyphenol-carbohydrate dual-modification strategy.
Article in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine lactoferrin was widely used in food industry but suffered from resource dependence, environmental sensitivity and digestive inactivation susceptibility. As a promising alternative, the characteristics of plant-derived recombinant lactoferrin (OsrhLF) remained unclear. Herein, novel OsrhLF-EGCG-Mal ternary covalent complexes were innovatively constructed via dual-modification strategy with epigallocatechin gallate (EGCG) and maltodextrin (Mal). Results confirmed that covalent conjugation altered the spatial conformation of OsrhLF and affected its antioxidant activity, EGCG and Mal exerted effect on OsrhLF against gastrointestinal digestion. Analysis of short-chain fatty acid (SCFAs) in vitro feces fermentation verified the regulatory role of the OsrhLF-EGCG-Mal. Finally, the OsrhLF-EGCG-Mal enhanced water-holding capacity of the apple matrix, a critical functional advantage - in food processing and preservation. This study not only addressed the key shortcomings of lactoferrin application in food systems but also expanded the industrial application of OsrhLF in the field of food chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.